DRUG TREATMENT OF ASTHMA Asrar B. Malik, Ph.D
|
|
- Christian Nichols
- 8 years ago
- Views:
Transcription
1 DRUG TREATMENT OF ASTHMA Asrar B. Malik, Ph.D DRUGS USEFUL IN ASTHMA LEARNING OBJECTIVES 1. Know the working definitions of asthma and basic pathology of the disease. 2. Understand the role of various cell types and mediators in the pathogenesis of asthma. 3. Be familiar with autonomic innervation of the lung as it relates to asthma. 4. Know the rationale for the use of β-agonist therapy and its associated side effects. 5. Know the therapeutic actions of cromolyn and the rationale for its use. 6. Understand the rationale for the current trends in the use of corticosteroids for the treatment of asthma, and know the frequently used steroid analogs. 7. Understand the therapeutic actions and precautions in the use of theophylline and its analogs for the treatment of asthma. DRUG LIST SUBCLASS PROTOTYPE ANALOGS sympathomimetic epinephrine metaproterenol albuterol terbutaline salmeterol mast cell stabilizer cromolyn sodium nedocromil Na corticosteroid prednisone beclomethasone triamcinolone xanthine caffeine theophylline enprophylline aminophylline ASTHMA: Asthma is described as "the presence of prevalent narrowing of airways, which alters in severity either spontaneously or in response to treatment and which is characterized by increased Page 1 of 14
2 responsiveness of the trachea and bronchi to provocative stimuli". The basic abnormality of asthma is recognized to be increased excitability of smooth muscle or BHR (bronchial hyperresponsiveness, defined below). However, asthma cannot be defined in terms of BHR alone because: 1. BHR in response to bronchial constrictors is found in some subjects without symptoms of asthma 2. asthma can be induced by allergens in subjects who do not show BHR to bronchial constrictors Thus, the classical definition of asthma is not ideal; it avoids the assignment of a unique pathogenesis and pathology, and it fails to explain the different types of asthma. Accordingly, the definition of asthma is being refined as new information about its etiology becomes available. Working definitions: Asthma Atopy The presence of intermittent symptoms such as chest tightness, wheeze, and cough, together with demonstrable BHR. Production of IgE antibodies in response to aeroallergens (type I response). BHR (Bronchial Hyperresponsiveness) A 20% decrease in FEV 1 (Forced Expiratory Volume in I second) in response to a provoking factor that causes less than a 5% decrease in normal subjects (at the same dose); or a 20% increase in FEV 1 in response to an inhaled bronchodilating drug. (In asthmatics, the FEV 1 response to histamine or methacholine is 10- to 100-fold greater than normal subjects.) Early and Late Asthmatic Responses! Early: airway narrowing within 15 minutes after exposure to precipitating agent or episode; usually reverses in 30 to 60 minutes.! Late: occurs 4-8 hours later; may or may not follow early response (usually in occupational asthma). Page 2 of 14
3 Classifications of Asthma Extrinsic : Intrinsic: Occupational: asthma occurring in an atopic patient; can result in acute attacks; e.g. pollen asthma, exercise-induced asthma. no evidence of atopy; often begins in adults; can be chronic in nature. occurs with exposure to provoking agents at the workplace; symptoms usually lessen upon withdrawal from agent. Pathology of asthma: Bronchial wall in asthma (diagrammatic). Note the hypertrophied, contracted smooth muscle, edema, mucous gland hypertrophy, and secretion in lumen. General: 1. overinflated lungs that do not deflate upon pneumothorax 2. widespread mucous plugging of airways 3. no emphysematous changes Microscopic: 1. airway smooth muscle hypertrophy 2. bronchial mucosal edema 3. infiltration with eosinophils 4. desquamation of airway epithelium Page 3 of 14
4 Cells of Airway in Asthma 1. Bronchial smooth muscle: 1. abnormal in severe asthmatics 2. contractile response is supra-normal; relaxation is abnormal 2. Mediator-releasing cells: a. mast cells: 1. found on entire length of airway epithelium 2. cell numbers increased in asthmatics 3. in allergic asthma, release mediators at lower doses of secretagogues b. basophils: 1. involved in late phase of allergic reactions 2. in asthmatics, circulating basophils are hyperresponsive to histamine secretagogues 3. Mononuclear cells: Page 4 of 14
5 a. Macrophages: 1. scavengers in airways and alveoli; process antigens for presentation to lymphocytes 2. stimulate mediator release from mast cells b. Lymphocytes: 1. B-lymphocytes hypersecrete IgE (atopy) 2. T-helper cells make mast cell secretagogues (e.g. IL-3, eosinophil activating, and chemotactic factors) 4. Vascular endothelial cells: a. airway edema results from protein and fluid leakage from microvasculature b. endothelial cells contract in response to histamine, leukotrienes, and substance P 5. Eosinophils: a. infiltrate airways in asthma in response to mast cell-derived chemotactic factors b. release tissue-damaging proteins involved in the epithelial shedding; e.g. Major Basic Protein (MBP). 6. Airway epithelial cells: a. produce mediators; e.g. 5-HETE, LTB4, PGE 2 b. frequently shed in asthma as result of leukocyte adherence and transmigration c. epithelial shedding and increased epithelial permeability involved in development of bronchial hyperresponsiveness; tracheal segments devoid of epithelium show increased responsiveness to bronchoconstrictors (see figure 10-1 below) Figure Influence of airway epitheliuin (EP) on smooth muscle responses. Contractile response of bovine tracheal smooth muscle to histamine with (EP +) or without (EP -). Each point is the mean (+/-SEM) of ten observations. (Reprinted with permission from Barnes, P. J., Cuss, F. M. C., Palmer, J. B. D.: The effect of airway epithelium on smooth muscle contractility in bovine trachea (Br. J. Pharmacol. 86: , 1995) Page 5 of 14
6 7. Mucous-secreting cells (goblet cells, mucous glands): a. mucous plugging is common b. mucous secretion stimulated by cholinergic agonists and mast cell mediators 8. Role of mediators in asthma: a. histamine: 1. bronchoconstrictor 2. vasodilator 3. potently released in diseases in which BHR is not found; thus it is not likely that histamine solely causes BHR b. eosinophil chemotactic factor (ECF): 1. involved in development of BHR through damage to airway epithelium by eosinophil-derived MBP (see above) 2. released after allergic and exercise challenge c. "newly generated factors": 1. traditional term for prostaglandins and leukotrienes 2. important in asthma Summary of Basic Mechanisms Underlying Asthma 1. Intrinsic Asthma (lower pathway) a. T-lymphocytes are activated directly by allergens, then secrete lymphokines b. lymphokines activate eosinophils, which secrete mediators and damaging proteins c. mediators potentiate inflammation and damage epithelium, enhancing BHR d. important in chronic form of asthma Page 6 of 14
7 2. Extrinsic Asthma (upper pathway) a. allergens (or other stimuli) directly activate mast cells and/or eosinophils through surface-bound IgE b. released mediators elicits bronchoconstriction and can lead to chronic symptoms as well c. involved in severe acute attacks Autonomic Nervous System in Asthma Autonomic control of human airways 1. Beta-adrenergic system a. No direct sympathetic nerve supply to bronchial smooth muscle in humans b. $2-adrenoceptors are found along the bronchial tree on bronchial smooth muscle; agonists cause relaxation of BSM and bronchodilation c. Asthmatics rely on circulating catecholamines for $2-receptor stimulation (lower levels at night are associated with decreased lung function) d. $2-adrenoceptors are altered asthmatics in that long-term use of $-agonists does not desensitize the $-receptors as it does in normal or atopic subjects e. Asthmatics respond well to $-receptor agonists; if given by aerosol, bronchial responsiveness becomes normal for a short period 2. Alpha adrenergic system a. Role in asthma poorly understood b. In asthmatics stimulation may cause bronchoconstriction c. Agonists stimulate mediator release from mast cells 3. Cholinergic system Page 7 of 14
8 a. Innervates bronchial smooth muscle and mucous glands throughout airways b. Dominant constrictor mechanism in airways; also stimulates mucous secretion c. No evidence of altered cholinergic receptors in asthma In asthmatics, the afferent side of the cholinergic reflex is active due to changes in the exposure or sensitivity of the bronchial sensory nerve endings. This leads to reflex contraction of bronchial smooth muscle and mucous secretion. The idea supported by the ability of cholinergic blockers to protect some patients against allergen-or exercise-induced asthma. THERAPEUTIC TREATMENT OF ASTHMA There are two basic approaches in treatment of asthma: 1. interruption of function of inflammatory cells and mediator-releasing cells: 2. taking advantage of neural control of airway function. Systemically delivered drugs formed the basis for asthma therapy. Now the use of aerosols has increased: Aerosols: 1. provide high local dose (thus minimize side effects) 2. protect against provoking agents (systemically delivered drugs do not) β2 ADRENOCEPTOR AGONISTS Epinephrine has been used in the treatment of asthma since the beginning of the century; dessicated adrenal gland was given to asthmatics because it was believed to decrease airway swelling in the same way that it could blanch the skin. Since the bronchodilation is mediated through β2-receptors and the cardiac effects are mediated through βl-receptors, selective β2-agonists such as albuterol and terbutaline were introduced in the l960's. Salmeterol was introduced recently. Therapeutic actions of β2-agonists: 1. relax contracted bronchial smooth muscle 2. prevent bronchial smooth muscle contraction by various stimuli 3. increase mucous clearance 4. prevent mast cell mediator release 5. prevent edema induced by histamine, etc. by preventing increase in endothelial permeability Choice of drugs: 1. epinephrine Page 8 of 14
9 Delivery: a. not a good choice for asthma b. lacks $ 2 -receptor selectivity; $1-mediated cardiac effects c. short duration of action due to rapid uptake and metabolism d. its α-agonist activity is bronchoconstrictive 2. metaproterenol a. moderately selective β-agonist b. not a substrate for COMT; thus, longer duration of action c. given by inhalation 3. β2 -selective agonists (albuterol, terbutaline, salmeterol) a.. effective in bronchodilation, but no cardiac effects b. longer duration of action; not substrates for COMT c. available by inhalation and orally; similar duration of action (3-4 hrs) d. salmeterol is a nearly pure β2-selective, the others mostly β2 e. in general terbutaline: orally; albuterol: inhalation; salmeterol: inhalation but it is ONLY for prophylaxis because of slow onset and long t 1/2 1. by aerosol: a. good protection against provokers including allergens, exercise, histamine, and methacholine (mild to moderately severe asthma only) b. severe asthma: aerosol alone may not protect against all provokers, and inhaled cromolyn or corticosteroids may also be necessary (see below) c. often used in conjunction with other drugs; e.g. to promote better delivery of cromolyn or corticosteroids to the distal airways. 2. systemically: Side Effects: a. available orally and for injection b. weak therapeutic effects only; side effects greater c. use only if aerosol administration is excluded d. exception: sustained release forms useful for nocturnal asthma 1. due to extrapulmonary $2-receptors: dose-related and unusual with inhalation 2. muscle tremor due to skeletal muscle $-receptors 3. Tachycardia and palpitations due to reflex cardiac stimulation secondary to peripheral vasodilation, direct stimulation of atrial $1 receptors, and possible direct stimulation of myocardial $1 receptors 4. tolerance to side effects after prolonged use 5. metabolic effects: increased FFA, glucose, lactate after large systemic doses 6. hypokalemia (due to stimulation of K + entry into skeletal muscle) Page 9 of 14
10 7. V/Q mismatching due to pulmonary vasodilation 8. asthmatics do not develop tolerance to $2-agonists as normal subjects Traditionally, there has been a reluctance to use $2 agonists resulting from the mistaken impression that they have severe side effects. However, these are minimized at the relatively low doses delivered by metered dose inhalers. Clinical uses 1. the most widely used and effective bronchodilators 2. inhalers easy to use; effects are rapid and side effects are few 3. also protect against exercise-, cold air-and allergen indued asthma 4. bronchodilator of choice for acute asthma if used in nebulizer SODIUM CROMOGLYCATE (cromolyn sodium) Cromolyn sodium has been used in the U.S. for treatment of asthma since Therapeutic Actions: primarily prophylactic 1. when administered before challenge, it inhibits the response to: a. exercise b. allergens c. cold air 2. in long-term treatment: a. prevents early and late responses to allergens b. decreases bronchial responsiveness Mechanism of Action 1. mast cell stabilization a. inhibition of degranulation by a variety of stimuli, including cell-bound IgEallergen interactions b. inhibition of leukotriene production c. above actions due to blockage of calcium influx into mast cells 2. other cells a. suppresses release of chemoattractant peptides that recruit eosinophils, neutrophils, or monocytes b. reverses elevated receptor expression on leukocytes of asthmatic patients undergoing allergen challenge 3. no bronchodilator or antihistamine activity Page 10 of 14
11 Delivery Less than 1% of an oral dose of cromolyn is absorbed, so therapeutic effects are achieved through local administration via inhalation: Toxicity Uses 1. in 4% solution - by aerosol spray or nebulizer 2. powdered drug - as capsules to use in powered turbo-inhaler or as a metered dose inhaler 1. generally well-tolerated 2. infrequent adverse reactions: bronchospasm, cough, laryngeal edema, joint swelling or pain, headache rash, nausea 3. very rarely - anaphylaxis Prophylaxis of mild to moderate asthma, especially allergic asthma. Often administered in conjunction with an inhaled $2-agonist; e.g. albuterol, to ensure better access of cromolyn to the distal airways. Also used in allergic rhinitis. Nedocromil Sodium: has the same mechanism of action and uses as does cromolyn. There is no clinical difference. CORTICOSTEROIDS Systemic administration of corticosteroids has formed the basis for treatment of severe chronic or acute asthma since the 1950s. The side effects of systemically administered steroids are severe; however, recent development of aerosol forms has led to the re-evaluation of the therapeutic role of systemic administration in asthma. The most commonly used analogs by aerosol administration include: 1. beclomethasone dipropionate 2. availability: nasal spray inhaler 3. triamcinolone acetonide Mechanisms of action due to anti-inflammatory properties 1. reduces number and activity of inflammatory cells in airways 2. inhibits release of arachidonic acid metabolites 3. prevents increased vascular permeability 4. suppresses IgE binding 5. increases β-adrenergic responsiveness Page 11 of 14
12 Delivery 1. aerosol a. low- and high-dose forms b. few serious side effects c. favored for treatments lasting more than two weeks 2. oral or IV a. traditional route, especially when high doses required b. may not provide drug concentration sufficient to reach airway mucosa c. serious side effects have led to development of inhaled forms d. use for the shortest possible duration! e. for severe episodes: prednisone Goal: use lowest possible dose and use concurrently with β2-agonist therapy or oral theophylline (see below). Side Effects of inhaled preparations Clinical uses 1. dysphonia 2. oropharyngeal candidiasis 3. both can be reduced by mouth rinsing with water after administration and through use of appropriate spacers with the inhaler to avoid oral deposition. 1. for severe episodes 2. for prophylaxis (no acute beneficial effect) 3. little effect on early response, but will suppress late response to allergen challenge 4. indicated for patients who respond inadequately to cromolyn THEOPHYLLINE The bronchodilating effect of strong coffee was originally described by Hyde Salter during the last century. Methylxanthines have been used for treatment of asthma since Several derivatives are available, but none appear to be better than theophylline, though enprofylline (3-propylxanthine) may be more potent. Many xanthine salts are available; the most common, aminophylline, has increased solubility at neutral ph, rendering it useful for intravenous administration. Other salts have little advantage over aminophylline. Major therapeutic actions 1. relaxes bronchial smooth muscle 2. decreases mast cell mediator release Page 12 of 14
13 3. increases mucocilliary clearance 4. prevents microvascular leakiness Mechanisms of action 1. inhibition of phosphodiesterases a. increase intracellular camp 2. adenosine receptor antagonism a. adenosine causes bronchoconstriction in asthmatics b. bronchoconstriction prevented by theophylline at therapeutic concentrations c. however, enprofylline has no effect on adenosine-mediated bronchoconstriction 3. other a. increased epinephrine secretion form adrenal medulla; increase small and cannot account for the bronchodilation b. antagonizes some prostaglandins in smooth muscle Administration 1. Ineffective by inhalation; requires build-up of effective plasma concentration 2. Intravenous; for severe acute asthma only 3. Orally, (not recommended) tablets or elixir give wide fluctuations in plasma levels; however, sustained release preps can achieve a steady plasma concentration over 24 hr and are good for nocturnal asthma. A single dose of a slow-release preparation is often effective. Avoid mixtures of theophylline and β agonists or sedatives. Pharmacokinetics Dosage required to achieve an effective blood concentration varies considerably because of clearance factors: 1. theophylline is rapidly and completely absorbed 2. large differences in clearance rates due to hepatic metabolism by P450 system; factors affecting this include: increased clearance -induction of P450 by: rifampicin, phenobarbitone childhood high protein, low carbohydrate decreased clearance -reduced P450 by : cimetidine, erythromycin, allopurinol congestive heart failure pneumonia 3. dosage should be individualized; plasma levels should be measured after dosing with slow-release preps until steady-state is achieved. Page 13 of 14
14 Side effects Significant when plasma concentration reaches 20 mg/ml or higher low concentrations: headache, restlessness, increased acid secretion, diuresis high concentrations: convulsions, cardiac arrythmias in some patients CNS stimulation, possibly from adenosine receptor antagonism enprophylline has no adenosine receptor; antagonism at bronchodilating doses control side effects: initial dose should be light, rising slowly until the therapeutic plasma level is reached Clinical Uses theophylline: reverses bronchoconstriction in asthmatics, but is less potent than $-agonists drug of choice for nocturnal asthma since slow-release preps are more effective than slow-release $2-agonist preps theophylline and $2-agonists: have additive effects on bronchodilation, so if $2-agonist therapy alone does not offer relief, theophylline can be added to the regimen Page 14 of 14
RSPT 2317 Non-steroidal anti-asthma agents
RSPT 2317 Non-steroidal Anti-asthma Agents Mechanisms of Inflammation in Asthma Mechanisms of Inflammation in Asthma Asthma is a chronic inflammatory disorder of the airways It is divided into extrinsic
More informationFrom the Text. Clinical Indications. Clinical Indications. RSPT 2217 Non-steroidal Anti-asthma Agents. RSPT 2317 Non-steroidal Antiasthma Agents
From the Text RSPT 2317 Non-steroidal Antiasthma Agents Gardenhire Chapter 12 Key Terms and Definitions Page 226 Nonsteroidal Antiasthma Meds Table 12-1; page 228 Comparative Features of Antileukotriene
More informationCompare the physiologic responses of the respiratory system to emphysema, chronic bronchitis, and asthma
Chapter 31 Drugs Used to Treat Lower Respiratory Disease Learning Objectives Describe the physiology of respirations Compare the physiologic responses of the respiratory system to emphysema, chronic bronchitis,
More informationOn completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children
7 Asthma Asthma is a common disease in children and its incidence has been increasing in recent years. Between 10-15% of children have been diagnosed with asthma. It is therefore a condition that pharmacists
More informationThe Annual Direct Care of Asthma
The Annual Direct Care of Asthma The annual direct health care cost of asthma in the United States is approximately $11.5 billion; indirect costs (e.g. lost productivity) add another $4.6 billion for a
More informationChapter 20. Drugs Used in Asthma
Nitric Oxide (INOmax) Inhalation: 100, 800 ppm gas Katzung PHARMACOLOGY, 9e > Section IV. Drugs with Important Actions on Smooth Muscle > Chapter 19. Nitric Oxide, Donors, & Inhibitors > Chapter 20. Drugs
More informationHypersensitivity. TYPE I Hypersensitivity Classic allergy. Allergens. Characteristics of allergens. Allergens. Mediated by IgE attached to Mast cells.
Gel and Coombs classification of hypersensitivities. Hypersensitivity Robert Beatty Type I Type II Type III Type IV MCB150 IgE Mediated IgG/IgM Mediated IgG Mediated T cell Classic Allergy rbc lysis Immune
More informationDrug therapy SHORT-ACTING BETA AGONISTS SHORT-ACTING ANTICHOLINERGICS LONG-ACTING BETA AGONISTS LONG-ACTING ANTICHOLINERGICS
Drug therapy 6 6.1 What is the role of bronchodilators in COPD? 52 SHORT-ACTING BETA AGONISTS 6.2 How do short-acting beta agonists work? 52 6.3 What are the indications for their use? 52 6.4 What is the
More informationDRUG UTILISATION STUDY IN BRONCHIAL ASTHMA IN A TERTIARY CARE HOSPITAL
International Journal of Pharmaceutical Applications ISSN 0976-2639, Online ISSN 2278 6023 Vol 3, Issue 2, 2012, pp 297-305 http://www.bipublication.com DRUG UTILISATION STUDY IN BRONCHIAL ASTHMA IN A
More informationAdrenergic agonists:-
Adrenergic agonists:- A.) Catecholamines They are called catecholamines because they contain a catechol group, they are water-soluble and are 50% bound to plasma proteins, so they circulate in the bloodstream.
More informationSMO: Anaphylaxis and Allergic Reactions
REGION I EMERGENCY MEDICAL SERVICES STANDING MEDICAL ORDERS EMT Basic SMO: Anaphylaxis and Allergic Reactions Overview: Allergic reactions can vary in severity from a mild reaction consisting of hives
More informationPre-Operative Services Teaching Rounds 2 Jan 2011
Pre-Operative Services Teaching Rounds 2 Jan 2011 Deborah Richman MBChB FFA(SA) Director Pre-Operative Services Department of Anesthesia Stony Brook University Medical Center, NY drichman@notes.cc.sunysb.edu
More information8/6/2010. Name of medication Concentration (1:1,000 or 1mg/1ml) Expiration date
Learning Objectives: Anaphylaxis & Epinephrine Administration by the EMT Adapted with permission from the Pilot Project for the Administration of Epinephrine by Washington EMTs With successful completion
More informationANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY. Guidelines for Use of Intravenous Isoproterenol
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY Guidelines for Use of Intravenous Isoproterenol Major Indications Status Asthmaticus As a last resort for
More informationADRENERGIC RECEPTOR AGONIST,CLASSIFICATION AND MECHANISM OF ACTION.
ADRENERGIC RECEPTOR AGONIST,CLASSIFICATION AND MECHANISM OF ACTION. LEARNING OBJECTIVES At the end of lecture students should be able to know, Adrenergic receptor agonist, Classification and mechanism
More informationPATIENT INFORMATION ABOUT TREATMENTS FOR ASTHMA AND ALLERGIC RHINITIS, PRESCRIPTIONS & OVER THE COUNTER MEDICINE
PATIENT INFORMATION ABOUT TREATMENTS FOR ASTHMA AND ALLERGIC RHINITIS, PRESCRIPTIONS & OVER THE COUNTER MEDICINE The content of this booklet was developed by Allergy UK. MSD reviewed this booklet to comment
More information1. The potential sites of action for sympathomimetics and the difference between a direct and indirect acting agonist.
1 OBI 836 The Autonomic Nervous System-Sympathomimetics M.T. Piascik August 29, 2012 Learning Objectives Lecture II The student should be able to explain or describe 1. The potential sites of action for
More informationPharmacology - Problem Drill 06: Autonomic Pharmacology - Adrenergic System
Pharmacology - Problem Drill 06: Autonomic Pharmacology - Adrenergic System Question No. 1 of 10 Instructions: (1) Read the problem and answer choices carefully, (2) Work the problems on paper as 1. What
More informationunderstanding the professional guidelines
SEVERE ASTHMA understanding the professional guidelines This guide includes information on what the European Respiratory Society (ERS) and the American Thoracic Society (ATS) have said about severe asthma.
More informationMontelukast Sodium Singulair, Merck. Development and Pharmacology: 1
Montelukast Sodium Singulair, Merck Development and Pharmacology: 1 Asthma is a chronic inflammatory disease of the airways that is complicated by episodes of acute inflammation. Even patients with mild
More informationMontelukast Sodium. -A new class of seasonal allergic rhinitis therapy
Montelukast Sodium -A new class of seasonal allergic rhinitis therapy Symptoms of Seasonal Allergic Rhinitis Nasal itch Sneezing Rhinorrhoea Nasal stuffiness Pathogenesis of Allergic Rhinitis Mast cells,
More informationMedicines Use Review Supporting Information for Asthma Patients
Medicines Use Review Supporting Information for Asthma Patients What is asthma? Asthma is a chronic inflammatory disorder of the airways. The inflammation causes an associated increase in airway hyper-responsiveness,
More informationYOU VE BEEN REFERRED TO AN ASTHMA SPECIALIST...
YOU VE BEEN REFERRED TO AN ASTHMA SPECIALIST... ...HERE S WHAT TO EXPECT You have been referred to an allergist because you have or may have asthma. The health professional who referred you wants you to
More informationBreathe Easy: Asthma and FMLA
This article was published in the FMLA Policy, Practice, and Legal Update newsletter, by Business & Legal Reports, Inc. (BLR). BLR is a nationally recognized publisher of regulatory and legal compliance
More informationAsthma in Infancy, Childhood and Adolescence. Presented by Frederick Lloyd, MD Palo Alto Medical Foundation Palo Alto, California
Asthma in Infancy, Childhood and Adolescence Presented by Frederick Lloyd, MD Palo Alto Medical Foundation Palo Alto, California Major Health Problem in Childhood Afflicts 2.7 million children in the USA
More information9/16/2014. Anti-Immunoglobulin E (IgE) Omalizumab (Xolair ) Dosing Guidance
Disclosure Statement of Financial Interest New Therapies for Asthma Including Omalizumab and Anti-Cytokine Therapies Marsha Dangler, PharmD, BCACP Clinical Pharmacy Specialist James H. Quillen VA Medical
More informationProtocol in depth Asthma/COPD. daniel.dunham@clemc.us
Protocol in depth Asthma/COPD daniel.dunham@clemc.us Asthma/COPD Narrowing of airways (an H4 histamine response causing inflammation and mucous production), leading to wheezing on inspiration and exhalation.
More informationASTHMA IN INFANTS AND YOUNG CHILDREN
ASTHMA IN INFANTS AND YOUNG CHILDREN What is Asthma? Asthma is a chronic inflammatory disease of the airways. Symptoms of asthma are variable. That means that they can be mild to severe, intermittent to
More informationInformation for Behavioral Health Providers in Primary Care. Asthma
What is Asthma? Information for Behavioral Health Providers in Primary Care Asthma Asthma (AZ-ma) is a chronic (long-term) lung disease that inflames and narrows the airways. Asthma causes recurring periods
More informationPharmacology of the Respiratory Tract: COPD and Steroids
Pharmacology of the Respiratory Tract: COPD and Steroids Dr. Tillie-Louise Hackett Department of Anesthesiology, Pharmacology and Therapeutics University of British Columbia Associate Head, Centre of Heart
More informationPHENYLEPHRINE HYDROCHLORIDE INJECTION USP
PRESCRIBING INFORMATION PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 10 mg/ml Sandoz Canada Inc. Date of Preparation: September 1992 145 Jules-Léger Date of Revision : January 13, 2011 Boucherville, QC, Canada
More informationPrimary Care Paramedic. Diphenhydramine (Benadryl) Certification Package
Primary Care Paramedic Diphenhydramine (Benadryl) Certification Package 1 Welcome to the Primary Care Paramedic Diphenhydramine Certification package! The addition of Benadryl to your list of medications
More informationBackground information
Background information Asthma Asthma is a complex disease affecting the lungs that can be managed but cannot be cured. 1 Asthma can be controlled well in most people most of the time, although some people
More informationThe asthmatic patient and sedation
The asthmatic patient and sedation Introduction The sedation practitioner is often faced with difficult questions to answer before the administration of sedation. Our guidelines say clearly that we are
More informationTreatments for allergy are usually straightforward, safe and effective. Common treatments include:
Allergy Medications The treatments prescribed for allergy control the symptoms and reactions; they do not cure the condition. However, using treatments as prescribed can show a huge change in a patient
More informationStacie L. Penkova, PharmD, MHSA, BCPS Clinical Pharmacy Manager Critical Care Pharmacy Specialist Drug Information Coordinator Pharmacology Summit
Stacie L. Penkova, PharmD, MHSA, BCPS Clinical Pharmacy Manager Critical Care Pharmacy Specialist Drug Information Coordinator Pharmacology Summit July 26, 2014 Objectives Classify asthma by severity Prescribe
More informationSynopsis of Causation
Ministry of Defence Synopsis of Causation Bronchial Asthma Author: Dr David Jenkins, Medical Author, Medical Text, Edinburgh Validator: Professor Stephen Holgate, Southampton General Hospital, Southampton
More informationMedications. Patient Education Pulmonary Rehabilitation. A guide to medications for Chronic Obstructive Pulmonary Disease (COPD) Introduction
Patient Education A guide to medications for Chronic Obstructive Pulmonary Disease (COPD) Do you know how each of your inhalers works to help your breathing? Do you know the correct order in which to use
More informationAdrenergic agonists. R. A. Nimmi Dilsha Department of pharmacy Faculty of Health Sciences The Open University of Sri Lanka
Adrenergic agonists R. A. Nimmi Dilsha Department of pharmacy Faculty of Health Sciences The Open University of Sri Lanka Outline Recall Introduction to adrenergic agonists Classification of adrenergic
More informationVPM 152. INFLAMMATION: Chemical Mediators
General Pathology VPM 152 INFLAMMATION: Chemical Mediators CHEMICAL MEDIATORS OF INFLAMMATION Definition: any messenger that acts on blood vessels, inflammatory cells or other cells to contribute to an
More informationSign up to receive ATOTW weekly - email worldanaesthesia@mac.com
ADRENALINE (EPINEPHRINE) ANAESTHESIA TUTORIAL OF THE WEEK 226 6 TH JUNE 2011 Prof. John Kinnear Southend University Hospital NHS Foundation Trust, UK Correspondence to John.Kinnear@southend.nhs.uk QUESTIONS
More informationAdrenergic, Adrenergic Blockers, Cholinergic and Cholinergic Blockers
Adrenergic, Adrenergic Blockers, Cholinergic and Cholinergic Blockers Objective 1: Explain the difference between the sympathetic and parasympathetic nervous systems Autonomic Nervous System Sympathetic
More informationEpinephrine Administration by the EMT
Epinephrine Administration by the EMT Pilot Project for the Administration of Epinephrine by Washington EMTs Tamara Coulter BS, FF/PM and Captain/MSO Steven Engle North Kitsap Fire & Rescue Objectives
More informationLESSON ASSIGNMENT. 7-4. Given a group of statements, select the best definition of the term adrenergic (sympathomimetic) drug.
LESSON ASSIGNMENT LESSON 7 Adrenergic Agents. TEXT ASSIGNMENT Paragraphs 7-1 through 7-6. LESSON OBJECTIVES 7-1. Given a group of statements, select the mechanism(s) of action of drugs which stimulate
More informationAsthma. SS Visser, Lung Unit, UP
Asthma SS Visser, Lung Unit, UP Contents Definition Disease Pattern Prevalence Mortality Etiology Pathogenesis Triggers of acute attacks Contents Pathophysiology Manifestations of Resp failure Diagnosis:
More informationThe patient s response to therapy within the first hour in the Emergency Room is one of the most reliable ways to predict need for hospitalization.
Emergency Room Asthma Management Algorithm The Emergency Room Asthma Management Algorithm is to be used for any patient seen in the Emergency Room with the diagnosis of asthma. (The initial history should
More informationAllergies and Autoimmune Inner Ear Disease
Allergies and Autoimmune Inner Ear Disease Allergy is the term used to describe an over-reaction of the body to a substance that is normally harmless to most people. This substance is called an allergen,
More informationObjectives COPD. Chronic Obstructive Pulmonary Disease (COPD) 4/19/2011
Objectives Discuss assessment findings and treatment for: Chronic Obstructive Pulmonary Disease Bronchitis Emphysema Asthma Anaphylaxis Other respiratory issues Provide some definitions Chronic Obstructive
More informationResponse to Stress Graphics are used with permission of: Pearson Education Inc., publishing as Benjamin Cummings (http://www.aw-bc.
Response to Stress Graphics are used with permission of: Pearson Education Inc., publishing as Benjamin Cummings (http://www.aw-bc.com) Page 1. Introduction When there is an overwhelming threat to the
More informationASTHMA< Observation about treatment and education of patients in San Pablo Clinic, Heredia Costa Rica
ASTHMA< Observation about treatment and education of patients in San Pablo Clinic, Heredia Costa Rica Rachel Borovina, MSIV Lisa Troeger, MSIV University of California San Francisco IHCAI FOUNDATION 2001
More informationPackage leaflet: Information for the patient. Bricanyl Tablets 5 mg terbutaline sulfate
Package leaflet: Information for the patient Bricanyl Tablets 5 mg terbutaline sulfate Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationAnaphylaxis Management. Pic 1 Severe allergic reaction which led to anaphylaxis
1 Anaphylaxis Management Pic 1 Severe allergic reaction which led to anaphylaxis What is an allergic reaction? 2 An allergy is when someone has a reaction to something (usually a protein) which is either
More informationAsthma Medications. 2009 WebMD, LLC. All rights reserved. What Is Asthma? What Causes Asthma? What Are the Risks of Asthma?
Print Close 2009 WebMD, LLC. All rights reserved. Asthma Medications What Is Asthma? What Causes Asthma? What Are the Risks of Asthma? Medical Treatment Corticosteroid Inhalers Oral and Intravenous Corticosteroids
More informationCOPD PROTOCOL CELLO. Leiden
COPD PROTOCOL CELLO Leiden May 2011 1 Introduction This protocol includes an explanation of the clinical picture, diagnosis, objectives and medication of COPD. The Cello way of working can be viewed on
More informationAnd the. Two types of orders:
1 PHARMACOLOGY And the EMT-B 2 MEDICAL DIRECTION Must have Dr. s orders to administer any drug to a Pt Local medical director can override any state set protocols Two types of orders: On-line : verbal
More informationADRENERGIC AND ANTI-ADRENERGIC DRUGS. Mr. D.Raju, M.pharm, Lecturer
ADRENERGIC AND ANTI-ADRENERGIC DRUGS Mr. D.Raju, M.pharm, Lecturer SYMPATHETIC NERVOUS SYSTEM Fight or flight response results in: 1. Increased BP 2. Increased blood flow to brain, heart and skeletal muscles
More informationRSPT 1410 Common Respiratory Drugs
1 RSPT 1410 Wilkins: Chapter 32 2 Classifications Respiratory therapists administer several different class of drugs: (adrenergic) Parasympatholytics (anticholinergic) Mucoactives (mucolytic) Antiasthmatics
More informationAsthma. Micah Long, MD
Asthma Micah Long, MD Goals Define the two components of asthma. Describe the method of action and uses for: Steroids (inhaled and IV) Quick Beta Agonists (Nebs and MDIs) The "Others" Magnesium, Epi IM,
More informationinability to take a deep breath)
Algorithm for the diagnosis and management of asthma: a practice parameter update These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy,
More informationInetCE 146-000-01-001-H01
The National Asthma Education Prevention Program (NAEPP II) Guidelines for the Treatment of Asthma: Implications for the Pharmacist (Manuscript Updated December 2000) InetCE 146-000-01-001-H01 Theresa
More informationSupplemental Material CBE Life Sciences Education. Su et al.
Supplemental Material CBE Life Sciences Education Su et al. APPENDIX Human Body's Immune System Test This test consists of 31 questions, with only 1 answer to be selected for each question. Please select
More informationChronic obstructive pulmonary disease (COPD)
Chronic obstructive pulmonary disease (COPD) Chronic obstructive pulmonary disease (COPD) is the name for a group of lung diseases including chronic bronchitis, emphysema and chronic obstructive airways
More informationPulmonary Diseases. Lung Disease: Pathophysiology, Medical and Exercise Programming. Overview of Pathophysiology
Lung Disease: Pathophysiology, Medical and Exercise Programming Overview of Pathophysiology Ventilatory Impairments Increased airway resistance Reduced compliance Increased work of breathing Ventilatory
More informationAssessing the Asthmatic Airway Written by Lindell Forbes EMT-P
Assessing the Asthmatic Airway Written by Lindell Forbes EMT-P Asthma is a disease of great proportions world wide. It is estimated by the American Lung Association 17.7 million individuals are affected
More informationAdult Chemotherapy Induced Anaphylaxis Policy
Adult Chemotherapy Induced Anaphylaxis Policy The Beatson West of Scotland Cancer Centre 1053 Great Western Road Glasgow G12 0YN Written by: Elaine Barr Authorised by: D.Dunlop, C. Forte Issue Number :
More informationVISTARIL (hydroxyzine pamoate) Capsules and Oral Suspension
VISTARIL (hydroxyzine pamoate) Capsules and Oral Suspension DESCRIPTION Hydroxyzine pamoate is designated chemically as 1-(p-chlorobenzhydryl) 4- [2-(2-hydroxyethoxy) ethyl] diethylenediamine salt of 1,1
More informationGlossary of Terms. Section Glossary. of Terms
Glossary of Terms Section Glossary of Terms GLOSSARY Acute: Symptoms which can occur suddenly with a short and severe course. Adrenaclick /Generic Adrenaclick : a single use epinephrine auto-injector that
More informationCanine Chronic Bronchitis Lisa Shearer DVM, DVSc, Diplomate ACVIM (internal medicine)
Canine Chronic Bronchitis Lisa Shearer DVM, DVSc, Diplomate ACVIM (internal medicine) Chronic bronchitis (CB) is defined as a daily cough for greater than two months in which other causes of cough, such
More informationClassifying Asthma Severity and Initiating Treatment in Children 0 4 Years of Age
Classifying Asthma Severity and Initiating Treatment in Children 0 4 Years of Age Components of Severity Symptoms Intermittent 2 days/week Classification of Asthma Severity (0 4 years of age) Persistent
More informationAnaphylaxis and the Role of Diphenhydramine, Epinephrine and Ventolin
Anaphylaxis and the Role of Diphenhydramine, Epinephrine and Ventolin Dwayne Cottel Regional Paramedic Educator Matthew Davis Medical Director of Education Learning Objectives Describe the pathophysiology
More informationTests. Pulmonary Functions
Pulmonary Functions Tests Static lung functions volumes Dynamic lung functions volume and velocity Dynamic Tests Velocity dependent on Airway resistance Resistance of lung tissue to change in shape Dynamic
More informationWhat Medical Emergencies Should a Dental Office be Prepared to Handle?
What Medical Emergencies Should a Dental Office be Prepared to Handle? Gary Cuttrell, DDS, JD, University of NM Division of Dental Services Santiago Macias, MD, First Choice Community Healthcare Dentists
More informationInhaled and Oral Corticosteroids
Inhaled and Oral Corticosteroids Corticosteroids (steroids) are medicines that are used to treat many chronic diseases. Corticosteroids are very good at reducing inflammation (swelling) and mucus production
More informationManagement of Asthma
Federal Bureau of Prisons Clinical Practice Guidelines May 2013 Clinical guidelines are made available to the public for informational purposes only. The Federal Bureau of Prisons (BOP) does not warrant
More informationEMS Information Bulletin- #060
BUREAU OF EMERGENCY MEDICAL SERVICES EMS Information Bulletin- #060 DATE: October 27, 2008 SUBJECT: TO: FROM: Continuous Positive Airway Pressure for Basic Life Support Pennsylvania EMS Organizations &
More informationInfluenza (Flu) Influenza is a viral infection that may affect both the upper and lower respiratory tracts. There are three types of flu virus:
Respiratory Disorders Bio 375 Pathophysiology General Manifestations of Respiratory Disease Sneezing is a reflex response to irritation in the upper respiratory tract and is associated with inflammation
More informationKey Points. Autonomic Nervous System Drugs. Autonomic effects Sympathetic. Drugs can modify ANS activity by: Autonomic Nervous System
Key Points Autonomic Nervous System Drugs Autonomic drugs work at the synapses, Drugs either suppress or magnify the sympathetic or parasympathetic effect, Drugs don t work on a single target organ so
More information5. Treatment of Asthma in Children
Treatment of sthma in hildren 5. Treatment of sthma in hildren 5.1 Maintenance Treatment 5.1.1 rugs Inhaled Glucocorticoids. Persistent wheezing in children under the age of three can be controlled with
More informationFrom the Text. History & Development. History & Development. Clinical Indications. Clinical Indications. RSPT 2317 Sympathomimetics - Part 1
RSPT 2217 Adrenergic Bronchodilators (Sympathomimetics) Gardenhire Chapter 6 From the Text Key Terms and Definitions Page 104 Current Adrenergic Bronchodilators Table 6-1; page 106 Effects & Characteristics
More informationThe Ideal Local Anesthetic. Pain and Anxiety. Percent Solution. Contents cont: Contents of a dental cartridge
The Ideal Local Anesthetic Pain and Anxiety University of Minnesota Division of Oral and Maxillofacial Surgery Ma Ann C. Sabino, DDS PhD Water soluble/stable in solution Non-irritating to nerve Low systemic
More informationCHAPTER 21 QUIZ. Handout 21-1. Write the letter of the best answer in the space provided.
Handout 21-1 QUIZ Write the letter of the best answer in the space provided. 1. A severe form of allergic reaction is called A. an allergen. C. epinephrine. B. anaphylaxis. D. an immune reaction. 2. Harmless
More informationStrategies for Improving Patient Outcomes in Pediatric Asthma Through Education. Pediatric Asthma. Epidemiology. Epidemiology
Strategies for Improving Patient Outcomes in Pediatric Asthma Through Education Chris Orelup, MS3 Max Project 3/1/01 Pediatric Asthma The leading cause of illness in childhood 10, 000, 000 school absences
More informationRESPIRATORY VENTILATION Page 1
Page 1 VENTILATION PARAMETERS A. Lung Volumes 1. Basic volumes: elements a. Tidal Volume (V T, TV): volume of gas exchanged each breath; can change as ventilation pattern changes b. Inspiratory Reserve
More informationagainst allergic symptoms thought to be histaminic during a period of 1% minutes. No side effects When a dose of 30 mgm. of benadryl in 50 ml.
THE EFFECT OF ANTIHISTAMINE SUBSTANCES AND OTHER DRUGS ON HISTAMINE BRONCHOCONSTRICTION IN ASTHMATIC SUBJECTS' By JOHN J. CURRY (From the Evans Memorial and Massachusetts Memorial Hospitals, and the Department
More informationGuideline Statement for Treatment of Anaphylactic Reaction in the Surgical Patient
Adopted BOD October 2005 Updated BOD January 2013 Guideline Statement for Treatment of Anaphylactic Reaction in the Surgical Patient Introduction Anaphylaxis, also referred to as an anaphylactic reaction,
More informationThe Right Medicines Can Help You Get Control of Asthma. BlueCare SM TennCareSelect
The Right Medicines Can Help You Get Control of Asthma BlueCare SM TennCareSelect WHEEZING. COUGHING. SHORTNESS OF BREATH. CHEST TIGHTNESS. If you or a family member has asthma, you know these symptoms
More informationDrugs for treatment of respiratory diseases. Huifang Tang Department of pharmacology Zhejiang University, school of medicine tanghuifang@zju.edu.
Drugs for treatment of respiratory diseases Huifang Tang Department of pharmacology Zhejiang University, school of medicine tanghuifang@zju.edu.cn Antiasthmatic drugs Immunological and non-immunological
More informationACLS PHARMACOLOGY 2011 Guidelines
ACLS PHARMACOLOGY 2011 Guidelines ADENOSINE Narrow complex tachycardias or wide complex tachycardias that may be supraventricular in nature. It is effective in treating 90% of the reentry arrhythmias.
More informationNew 7/1/2015 MCFRS 1
New 7/1/2015 MCFRS 1 The providers will summarize the need for this change from an epinephrine auto injector The provider will define the proper dosage of epinephrine for the adult and pediatric patient
More informationImmunology and immunotherapy in allergic disease
Immunology and immunotherapy in allergic disease Jing Shen, MD Faculty Advisor: Matthew Ryan, MD The University of Texas Medical Branch Department of Otolaryngology Grand Rounds Presentation February 2005
More informationII. ASTHMA BASICS. Overview of Asthma. Why do I need to know about asthma?
II. ASTHMA BASICS Overview of Asthma Why do I need to know about asthma? In the United States, asthma is the most common chronic childhood illness. Asthma affects an estimated 4.8 million children nationally,
More informationmedicineupdate to find out more about this medicine
medicineupdate Asking the right questions about new medicines Seretide for chronic obstructive pulmonary disease What this medicine is 1 What this medicine treats 2 Other medicines available for this condition
More informationEFFIMET 1000 XR Metformin Hydrochloride extended release tablet
BRAND NAME: Effimet XR. THERAPEUTIC CATEGORY: Anti-Diabetic PHARMACOLOGIC CLASS: Biguanides EFFIMET 1000 XR Metformin Hydrochloride extended release tablet COMPOSITION AND PRESENTATION Composition Each
More informationSteroid treatment in cystic fibrosis
Steroid treatment in cystic fibrosis Factsheet March 2013 Steroid treatment in cystic fibrosis Introduction This factsheet contains information on steroid treatment in cystic fibrosis, including the different
More informationSTAGES OF SHOCK. IRREVERSIBLE SHOCK Heart deteriorates until it can no longer pump and death occurs.
STAGES OF SHOCK SHOCK : A profound disturbance of circulation and metabolism, which leads to inadequate perfusion of all organs which are needed to maintain life. COMPENSATED NONPROGRESSIVE SHOCK 30 sec
More informationChapter 13. Sympathetic Nervous System. Basic Functions of the Nervous System. Divisions of the Peripheral Nervous System
Chapter 13 Drugs Affecting the Autonomic Basic Functions of the Recognizing changes in Internal environment External environment Processing and integrating changes Reacting to changes Upper Saddle River,
More informationSalbutamol 1mg/ml Nebuliser Solution. Salbutamol 2mg/ml Nebuliser Solution PL 36390/0035 PL 36390/0036
Salbutamol 1mg/ml Nebuliser Solution Salbutamol 2mg/ml Nebuliser Solution PL 36390/0035 PL 36390/0036 UKPAR TABLE OF CONTENTS Lay summary Page 2 Scientific discussion Page 3 Steps taken for assessment
More informationANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1
AP BIOLOGY ANIMALS FORM & FUNCTION ACTIVITY #4 NAME DATE HOUR BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES Animals Form & Function Activity #4 page 1 INFLAMMATORY RESPONSE ANTIMICROBIAL
More informationBiologic Treatments for Rheumatoid Arthritis
Biologic Treatments Rheumatoid Arthritis (also known as cytokine inhibitors, TNF inhibitors, IL 1 inhibitor, or Biologic Response Modifiers) Description Biologics are new class of drugs that have been
More informationAsthma Glossary. Allergen
Action plan Acute Adverse Allergen Allergic asthma Allergic rhinitis Allergist Allergy Allergy shots Alveoli Anaphylaxis Antibiotic Antibodies Antihistamine Asthma Asthma Attack Breath sounds Bronchi (singular,
More information